We have been developing and manufacturing advanced optical instruments since 1982. Today, the majority of our business is the design and manufacture of high-quality medical devices. Approximately 8% of our revenue in fiscal year 2019 is from the design, manufacture and resale of optical products for military and defense and 13% for other industrial, non-medical products. Our medical instrumentation line includes traditional endoscopes and endocouplers as well as other custom imaging and illumination products for use in minimally invasive surgical procedures. Much of our recent development efforts have been targeted at the development of next generation endoscopes. Over the last ten years, we have funded internal research and development programs to develop next generation capabilities for designing and manufacturing 3D endoscopes and very small Microprecision™ lenses, anticipating future requirements as the surgical community continues to demand smaller and more enhanced imaging systems for minimally invasive surgery. Our unique proprietary technology in these areas, combined with recent developments in the areas of 3D displays and millimeter sized CMOS image sensors, has allowed us to begin commercialization of these technologies. Thus, approximately 30-40% of our revenues in each of the fiscal years 2017, 2018 and 2019 were derived from engineering and design services we performed for our customers to incorporate our technologies and capabilities into their medical device products. We believe that new products based on these technologies provide enhanced imaging for existing surgical procedures which help to enable development of many new medical device products and related medical procedures. Approximately 50-70% of our total revenues in fiscal years 2017, 2018 and 2019 were derived from the assembly and manufacture of endoscopic medical devises, sub-assemblies and optical components ordered by our customers and usually developed from the engineering and design services we perform for them. We expect sales revenue increases to come from the orders from our customers to manufacture the products we help them engineer and design.
Company profile
Ticker
POCI
Exchange
Website
CEO
Joseph Norman Forkey
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
Medtronic • Varian Medical Systems • Conmed • Integer • Masimo • Natus Medical • LivaNova • BioPlus Acquisition • QT Imaging • Outset Medical ...
Former names
PRECISION OPTICS Corp INC, PRECISION OPTICS CORPORATION INC
SEC CIK
Corporate docs
IRS number
42795294
POCI stock data
Latest filings (excl ownership)
10-K/A
2023 FY
Annual report (amended)
28 Feb 24
10-Q
2024 Q2
Quarterly report
14 Feb 24
8-K
Submission of Matters to a Vote of Security Holders
5 Dec 23
10-Q
2024 Q1
Quarterly report
14 Nov 23
S-8
Registration of securities for employees
26 Oct 23
DEF 14A
Definitive proxy
20 Oct 23
EFFECT
Notice of effectiveness
19 Oct 23
CORRESP
Correspondence with SEC
16 Oct 23
S-1/A
IPO registration (amended)
11 Oct 23
10-K
2023 FY
Annual report
28 Sep 23
Transcripts
POCI
Earnings call transcript
2024 Q2
14 Feb 24
POCI
Earnings call transcript
2024 Q1
14 Nov 23
POCI
Earnings call transcript
2023 Q4
28 Sep 23
POCI
Earnings call transcript
2023 Q3
15 May 23
POCI
Earnings call transcript
2023 Q2
14 Feb 23
POCI
Earnings call transcript
2023 Q1
14 Nov 22
POCI
Earnings call transcript
2022 Q4
28 Sep 22
POCI
Earnings call transcript
2022 Q3
17 May 22
POCI
Earnings call transcript
2022 Q3
16 May 22
POCI
Earnings call transcript
2022 Q2
15 Feb 22
Latest ownership filings
4
Peter H Woodward
17 Nov 23
4
Richard B Miles
17 Nov 23
4
Andrew J. Miclot
17 Nov 23
4
Peter V. Anania
17 Nov 23
4
Peter V. Anania
20 Jun 23
3
WAYNE M COLL
15 Jun 23
3
Mahesh Lawande
9 May 23
SC 13D
Anania Peter V.
14 Apr 23
4
Peter V. Anania
14 Apr 23
SC 13D/A
DOLPHIN OFFSHORE PARTNERS LP
20 Mar 23
Financial summary
Quarter (USD) | Sep 23 | Jun 23 | Mar 23 | Dec 22 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Jun 23 | Jun 22 | Jun 21 | Jun 20 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 1.37 mm | 1.37 mm | 1.37 mm | 1.37 mm | 1.37 mm | 1.37 mm |
Cash burn (monthly) | 518.46 k | (no burn) | 135.10 k | 78.50 k | 457.66 k | 137.82 k |
Cash used (since last report) | 3.57 mm | n/a | 929.52 k | 540.13 k | 3.15 mm | 948.24 k |
Cash remaining | -2.20 mm | n/a | 440.95 k | 830.34 k | -1.78 mm | 422.23 k |
Runway (months of cash) | -4.2 | n/a | 3.3 | 10.6 | -3.9 | 3.1 |
Recent insider trades
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
16 Nov 23 | Andrew J. Miclot | Stock Options (Rights to buy) Common Stock | Grant | Acquire A | No | No | 5.95 | 30,000 | 178.50 k | 89,998 |
16 Nov 23 | Peter V. Anania | Stock Options (Rights to buy) Common Stock | Grant | Acquire A | No | No | 5.95 | 30,000 | 178.50 k | 56,666 |
16 Nov 23 | Peter H Woodward | Stock Options (Rights to buy) Common Stock | Grant | Acquire A | No | No | 5.95 | 45,000 | 267.75 k | 135,000 |
16 Nov 23 | Richard B Miles | Stock Options (Rights to buy) Common Stock | Grant | Acquire A | No | No | 5.95 | 30,000 | 178.50 k | 90,998 |
16 Jun 23 | Peter V. Anania | Common Stock | Other | Acquire J | No | No | 0 | 4,827 | 0.00 | 201,648 |
News
Precision Optics Announces Receipt Of $720,000 Follow-On Production Order From Top Tier Defense/Aerospace CustomerFfor New Optical Application
18 Apr 24
Precision Optics Corp Q2 EPS $(0.13) Down From $0.11 YoY, Sales $4.82M Down From $5.89M YoY
14 Feb 24
Earnings Scheduled For February 14, 2024
14 Feb 24
Press releases
Precision Optics to Present at the Planet MicroCap Showcase: VEGAS 2024 on Wednesday, May 1, 2024 & 1x1 Meetings on Thursday, May 2, 2024
23 Apr 24
Precision Optics Reports Second Quarter Fiscal Year 2024 Financial Results
14 Feb 24
Precision Optics Corporation Schedules Second Quarter of Fiscal Year 2024 Conference Call for Wednesday, February 14, 2024
8 Feb 24